Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Linagliptin 5 mg Tablets vs Trajenta 5 mg Tablets in Healthy Thai Participants Under Fasting Conditions
TCTR20251021005Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of linagliptin (2 arms), sponsored by Bio-innova. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
linagliptin
Beyond the preview
Go deeper on TCTR20251021005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251021005.